The overall goal of this research proposal is to further define the biochemical, molecular and functional nature of the human kidney specific non-MHC alloantigens and evaluate their clinical significance in renal transplantation. We will employ antibodies specific for human kidney alloantigens eluted from rejected renal allografts, heteroantisera defining the non-MHC kidney antigen and T lymphocyte clones specific for human kidney antigens developed in our laboratories to achieve the above goals. Our results have shown that eluates from rejected kidneys, including HLA identical transplants, define a polymorphic 90kD alloantigen expressed on human kidneys. Affinity purified 90kD kidney alloantigen will be sequenced and compared to the sequences of 2 unique CDNA clones isolated by immunoscreening a human kidney expression vector library with eluates. Transfection experiments will also be carried out to establish whether the CDNA codes for molecules detected by eluates, heteroantisera and cytotoxic T lymphocyte clones. CD8+ human T lymphocyte clones developed in our laboratories are cytotoxic to kidney cell lines in an MHC class I restricted manner but not to other MHC identical cells indicating that the T cell clones are recognizing an organ specific non-MHC peptide in the context of MHC class I antigens. We will define isolated peptide antigen(s) from kidney cells for their ability to sensitize B- lymphoblastoid cell lines (B-LCL) for T cell mediated lysis including cyanogen bromide cleaved cytoplasmic extract from kidney cells, eluted peptides from HLA class I molecules from kidney cell lines, and peptides made from the sequenced 90kD protein. Sensitizing fractions will then be sequenced in order to define the HLA class I restricted peptide motif as well as determine the protein origin of the kidney specific antigen. In addition to defining the kidney specificity of 21 clones already available in our laboratories, we will produce additional T cell clones, using kidney cells as stimulatory cells, from normal peripheral blood and from kidney biopsies from renal transplant recipients undergoing acute, late and chronic rejections. These clones will be analyzed for cytotoxic specificity using kidney cell lines and B-LCL as targets. T cell receptor variable region of kidney cell specific clones will also be analyzed by Northern analysis or immunofluorescence in order to determine any predominant T cell receptor variable region usage. Thus, studies proposed in this application will provide important new information about the mechanism of chronic allograft rejection by establishing the functional significance of organ specific cytotoxic T lymphocytes in chronic rejection biopsies, and will lead to new avenues to treat chronic rejection which is not amenable to current protocols of immunosuppressive therapy.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Smith, Craig R; Jaramillo, Andres; Poindexter, Nancy J et al. (2002) In vitro T cell proliferation from kidney allograft biopsies with unremarkable pathology: new strategies for an old problem. Transplantation 73:142-5
Smith, C R; Mohanakumar, T; Shimizu, Y et al. (2000) Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Transplantation 69:294-9
SivaSai, K S; Jendrisak, M; Duffy, B F et al. (2000) Chimerism in peripheral blood of sensitized patients waiting for renal transplantation: clinical implications. Transplantation 69:538-44
Sivasai, K S; Mohanakumar, T; Phelan, D et al. (2000) Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates. Clin Exp Immunol 119:559-65
SivaSai, K S; Mohanakumar, T; Phelan, D et al. (1999) Down regulation of in vivo and in vitro T cell responses post cytomegalovirus immune globulin intravenous (human) administration in sensitized renal transplant candidates. Transplant Proc 31:1378-81
Shenoy, S; Mohanakumar, T; Todd, G et al. (1999) Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant 23:335-46
Poindexter, N J; Steward, N S; Mohanakumar, T (1999) Characterization of an HLA-A3 restricted human kidney specific T cell clone. Hum Immunol 60:939-43
Shenoy, S; Desch, K; Duffy, B et al. (1998) Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice. Clin Exp Immunol 112:188-95
Burlingham, W J; Grailer, A P; Heisey, D M et al. (1998) The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 339:1657-64
Poindexter, N; Shenoy, S; Howard, T et al. (1997) Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens. Clin Transplant 11:174-7

Showing the most recent 10 out of 28 publications